Response Genetics Inc. (RGDX) CFO Thomas Stankovich buys 7,000 Shares

Vice President and CFO of Response Genetics Inc. (RGDX, Financial) Thomas Stankovich buys 7,000 shares of RGDX on 12/14/2009 at an average price of $1.35 a share.

Response Genetics, Inc. is engaged in the research and development of pharmacogenomic cancer diagnostic tests based on its proprietary and patented technologies which enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin embedded specimens. RGI currently generates revenue primarily from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry. Response Genetics Inc. has a market cap of $22.18 million; its shares were traded at around $1.45 with and P/S ratio of 3.11.

Directors and Officers Recent Trades:

  • Buy:: 10% Owner Austin W & Greenhouse Da Marxe bought 200 shares of RGDX stock on 07/22/2009 at the average price of 1.2, the price of the stock has increased by 20.83% since

  • Buy:: 10% Owner Austin W & Greenhouse Da Marxe bought 200 shares of RGDX stock on 07/22/2009 at the average price of 1.2, the price of the stock has increased by 20.83% since

  • Buy:: 10% Owner Austin W & Greenhouse Da Marxe bought 200 shares of RGDX stock on 07/22/2009 at the average price of 1.2, the price of the stock has increased by 20.83% since

  • Buy:: 10% Owner Austin W & Greenhouse Da Marxe bought 1,700 shares of RGDX stock on 07/16/2009 at the average price of 1.14, the price of the stock has increased by 27.19% since

  • Buy:: 10% Owner Austin W & Greenhouse Da Marxe bought 2,600 shares of RGDX stock on 07/15/2009 at the average price of 1.1, the price of the stock has increased by 31.82% since